The toolkit is to offer a package of evaluation materials that can be used to determine the effect that expanded HIV screening activities has on patient attitudes toward and accepting HIV testing.

This information sheet provides recommendations from the CDC regarding the prevention of occupational transmission of HIV to health care workers (HCWs). The primary means of preventing the HCW's occupational exposure to HIV is to follow infection control precautions with the assumption that the blood and other body fluids from all patients are potentially infectious. Plans for postexposure management of HCWs should be in place, and the administration of antiretroviral drugs as postexposure prophylaxis (PEP) should be considered.

This poster is an infographic that describes the importance of HPV cancer prevention. It states that parents and healthcare professionals are the key to protecting adolescents from HPV cancers and recommends vaccinating 11-12 year olds.

This report reviews guidelines and strategies for preventing environment-associated infections in health-care facilities. It presents recommendations, including evidence-based recommendation supported by studies; requirements of federal agencies; guidelines and standards from building and equipment professional organizations; recommendations from scientific theory or rationale; and experienced opinions based upon infection-control and engineering practices. The report also suggests a series of performance measurements as a way of evaluating infection-control efforts.

This information sheet discusses the bacille Calmette-Guerin (BCG) vaccine for TB disease, which is used in many countries to prevent childhood tuberculous meningitis and miliary disease. It explains why the BCG is not generally recommended for use in the United States; suggests that the BCG should be considered under specific circumstances; and provides recommendations for when the BCG should be used with children and health care workers and contraindications when it should not be used, such as for immunosuppressed persons and pregnant women.

This information sheet discusses the bacille Calmette-Guerin (BCG) vaccine for TB, which is used in many countries to prevent childhood tuberculous meningitis and miliary TB. It explains why the BCG is not generally recommended for use in the United States; suggests that the BCG should be considered under specific circumstances; and provides recommendations for when the BCG should be used with children and health care workers, and contraindications when it should not be used, such as for immunosuppressed persons and pregnant women.

This serial contains CDC guidance that augments the 2011 recommendations of the Advisory Committee on Immunization Practices (ACIP) for evaluating hepatitis B protection among health-care personnel (HCP) and administering post-exposure prophylaxis. Although the rate of acute hepatitis B virus (HBV) infections have declined approximately 89% during 1990–2011, from 8.5 to 0.9 cases per 100,000 population in the United States, the risk for occupationally acquired HBV among HCP persists, largely from exposures to patients with chronic HBV infection.